Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib

Journal of Rheumatology

Volumn 27, Issue SUPPL. 60, 2000, Pages 25-28

  Goldstein, J L ^a  

^a Section of Digestive Liver Disease Medicine   (United States)

Author keywords

Celecoxib; Gastrointestinal system; NSAID

Indexed keywords

AZAPROPAZONE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; KETOPROFEN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ENZYME INHIBITION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; ULCER; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DIGESTIVE SYSTEM; DRUG EFFECT; NORTH AMERICA; PEPTIC ULCER; REVIEW; STOMACH ULCER; UNITED KINGDOM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DIGESTIVE SYSTEM; GREAT BRITAIN; HUMANS; NORTH AMERICA; PEPTIC ULCER; PYRAZOLES; STOMACH ULCER; SULFONAMIDES;

EID: 0034303179     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use
2. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: A prospective observational cohort study
3. Non-steroidal anti-inflammatory drugs and peptic ulcers
4. NSAID gastropathy: Epidemiology
5. NSAID gastropathy: A new understanding
6. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage
7. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
8. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease
9. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin. A case-control study
10. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
11. Gastrointestinal intolerance and bleeding with non-narcotic analgesics
12. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
13. NSAID induced gastrointestinal complications: The ARAMIS perspective - 1997
14. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial
15. Government affairs. FDA Arthritis Advisory Committee meeting: Risks of agranulocytosis/aplastic anemia, flank pain, and adverse gastrointestinal effects with non-steroidal anti-inflammatory drugs
16. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy
17. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulcerations
18. Regulation of fibroblast cyclooxygeanse synthesis by interleukin-1
19. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases
20. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes
21. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
22. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: From investigational trials to clinical experience
23. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
24. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor